Ginesa Rostan-Garcia
Valladolid, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction to: TERT Amplification a Risk Stratification Marker in Papillary Thyroid Carcinoma, Significantly Correlated with Tumor Recurrence and Survival.
Journal: Endocrine pathology
Published: October 30, 2025
TERT Amplification a Risk Stratification Marker in Papillary Thyroid Carcinoma, Significantly Correlated with Tumor Recurrence and Survival.
Journal: Endocrine pathology
Published: March 10, 2025
The Revolution of Targeted Therapies in Thyroid Cancer Treatment: Present and Future Promising Anti-Cancer Drugs.
Journal: International journal of molecular sciences
Published: February 19, 2025
Genomics Review of Selective RET Inhibitors Sensitivity in Thyroid Cancer Clinical Trials.
Journal: American journal of medical genetics. Part C, Seminars in medical genetics
Published: September 04, 2024
The phosphatidic acid phosphatase lipin-1 facilitates inflammation-driven colon carcinogenesis.
Journal: JCI insight
Published: September 14, 2017
A new role of the Rac-GAP β2-chimaerin in cell adhesion reveals opposite functions in breast cancer initiation and tumor progression.
Journal: Oncotarget
Published: February 15, 2016
Anaplastic thyroid carcinoma: molecular tools for diagnosis and therapy.
Journal: International journal of endocrinology
Published: December 18, 2014
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma.
Journal: Endocrine-related cancer
Published: August 25, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026